A Daver
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 7
- HER2/EGFR in Cancer Research 5
- Cancer-related Molecular Pathways 5
-
- Breast Cancer Treatment Studies 6
-
- Prostate Cancer Treatment and Research 6
-
- Radiopharmaceutical Chemistry and Applications 4
- Monoclonal and Polyclonal Antibodies Research 4
-
- Genetic factors in colorectal cancer 12
A Daver
46 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 75
- Oncology 361
- Endocrinology, Diabetes and Metabolism 193
- Cancer Research 144
- Pulmonary and Respiratory Medicine 270
- Radiology, Nuclear Medicine and Imaging 156
Countries citing papers authored by A Daver
This map shows the geographic impact of A Daver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Daver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Daver more than expected).
Fields of papers citing papers by A Daver
This network shows the impact of papers produced by A Daver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Daver. The network helps show where A Daver may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Daver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 5 | |
| 2 | 2004 | 14 | |
| 3 | 2003 | 9 | |
| 4 | 2001 | 77 | |
| 5 | [Standards, options and recommendations for tumor markers in colorectal cancer]. | 2001 | 14 |
| 6 | 2000 | 11 | |
| 7 | Specific H-Ras minisatellite alleles in breast cancer susceptibility. | 2000 | 9 |
| 8 | 2000 | 9 | |
| 9 | [Standards, Options and Recommendations (SOR) for tumor markers in breast cancer. SOR Working Group]. | 2000 | 16 |
| 10 | A new approach for clinical biological assay comparison and standardization: application of principal component analysis to a multicenter study of twenty-one carcinoembryonic antigen immunoassay kits. | 1999 | 14 |
| 11 | 1999 | 25 | |
| 12 | 1999 | 12 | |
| 13 | 1998 | 22 | |
| 14 | 1997 | 18 | |
| 15 | Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma. | 1997 | 47 |
| 16 | 1995 | 60 | |
| 17 | 1993 | 266 | |
| 18 | Méthodologie de la régression et de la prédiction fondée sur la classification automatique | 1991 | 2 |
| 19 | Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content. | 1987 | 16 |
| 20 | Monoclonal anticarcinoembryonic antigen in immunohistochemical studies of colorectal cancer a comparison with tumor and serum carcinoembryonic antigen content | 1985 | 1 |
About A Daver
A Daver is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (12 papers), Colorectal Cancer Treatments and Studies (7 papers), Breast Cancer Treatment Studies (6 papers), Prostate Cancer Treatment and Research (6 papers), HER2/EGFR in Cancer Research (5 papers), Cancer-related Molecular Pathways (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Oncology (361 citations), Endocrinology, Diabetes and Metabolism (193 citations) and Cancer Research (144 citations). A Daver has collaborated with scholars based in France and United States. Frequent co-authors include Jean-Louis Pujol, F Larra, Jean‐Christophe Grenier, J.-P. Daurès, H Pujol, F.B. Michel, Jean-Pierre Muratet, Jean‐Michel Bidart, F. Thuillier and Nelly Jacob. Their work appears in journals such as International Journal of Cancer, British Journal of Cancer, Oncology Reports, European Journal of Cancer and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.